Dark Forest Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.78M Buy
+26,935
New +$5.79M 0.44% 22
2025
Q1
– Sell
-4,235
Closed -$753K – 1199
2024
Q4
$753K Sell
4,235
-2,702
-39% -$497K 0.11% 261
2024
Q3
$1.37M Buy
+6,937
New +$1.29M 0.18% 122
2023
Q3
– Sell
-1,762
Closed -$237K – 1065
2023
Q2
$237K Buy
+1,762
New +$258K 0.02% 894
2022
Q3
– Sell
-1
Closed – – 1090
2022
Q2
$0 Sell
1
-63
-98% -$9.63K ﹤0.01% 855
2022
Q1
$10K Buy
+64
New +$9.3K ﹤0.01% 989
2021
Q4
– Sell
-1,246
Closed -$134K – 1380
2021
Q3
$134K Sell
1,246
-3,632
-74% -$415K 0.05% 312
2021
Q2
$549K Buy
+4,878
New +$549K 0.24% 27

Other funds holding ABBV

Dark Forest Capital Management's ABBV Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 26,935 shares worth $6.78M. The stake represents 0.44% of the portfolio and ranks #22 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in ABBV as recently as Q4 2024.

Dark Forest Capital Management first reported a position in ABBV in Q2 2021 and has held it in 8 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Dark Forest Capital Management held 26,935 shares of AbbVie worth $6.78M as of Q2 2026.
  • AbbVie was a new Dark Forest Capital Management position in Q2 2026.
  • AbbVie made up 0.44% of Dark Forest Capital Management's portfolio in Q2 2026, its #22 holding.
  • Dark Forest Capital Management first reported a position in AbbVie in Q2 2021 and has held it in 8 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.